Diamond Therapeutics Supports Health Canada Decision to Make Psilocybin Available through Special Access Program

/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental...

Related Keywords

United States ,Canada ,Toronto ,Ontario ,American ,Canadians ,Canadian ,Judy Blumstock ,Diamond Therapeutics Inc ,Dalton Pharma Services ,Health Canada ,Access Program ,Diamond Therapeutics ,Special Access Program ,Health Canada Approved ,Pharma Services ,North American ,Accelerated Stability Testing ,Health Care Amp Hospitals ,Mental Health ,Supplementary Medicine ,Medical Pharmaceuticals ,International Medical Approval ,